Cargando…
Targeting chromosome trisomy for chromosome editing
A trisomy is a type of aneuploidy characterised by an additional chromosome. The additional chromosome theoretically accepts any kind of changes since it is not necessary for cellular proliferation. This advantage led us to apply two chromosome manipulation methods to autosomal trisomy in chicken DT...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433146/ https://www.ncbi.nlm.nih.gov/pubmed/34508128 http://dx.doi.org/10.1038/s41598-021-97580-1 |
_version_ | 1783751316150943744 |
---|---|
author | Abe, Takuya Suzuki, Yuya Ikeya, Teppei Hirota, Kouji |
author_facet | Abe, Takuya Suzuki, Yuya Ikeya, Teppei Hirota, Kouji |
author_sort | Abe, Takuya |
collection | PubMed |
description | A trisomy is a type of aneuploidy characterised by an additional chromosome. The additional chromosome theoretically accepts any kind of changes since it is not necessary for cellular proliferation. This advantage led us to apply two chromosome manipulation methods to autosomal trisomy in chicken DT40 cells. We first corrected chromosome 2 trisomy to disomy by employing counter-selection markers. Upon construction of cells carrying markers targeted in one of the trisomic chromosome 2s, cells that have lost markers integrated in chromosome 2 were subsequently selected. The loss of one of the chromosome 2s had little impacts on the proliferative capacity, indicating unsubstantial role of the additional chromosome 2 in DT40 cells. We next tested large-scale truncations of chromosome 2 to make a mini-chromosome for the assessment of chromosome stability by introducing telomere repeat sequences to delete most of p-arm or q-arm of chromosome 2. The obtained cell lines had 0.7 Mb mini-chromosome, and approximately 0.2% of mini-chromosome was lost per cell division in wild-type background while the rate of chromosome loss was significantly increased by the depletion of DDX11, a cohesin regulatory protein. Collectively, our findings propose that trisomic chromosomes are good targets to make unique artificial chromosomes. |
format | Online Article Text |
id | pubmed-8433146 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84331462021-09-13 Targeting chromosome trisomy for chromosome editing Abe, Takuya Suzuki, Yuya Ikeya, Teppei Hirota, Kouji Sci Rep Article A trisomy is a type of aneuploidy characterised by an additional chromosome. The additional chromosome theoretically accepts any kind of changes since it is not necessary for cellular proliferation. This advantage led us to apply two chromosome manipulation methods to autosomal trisomy in chicken DT40 cells. We first corrected chromosome 2 trisomy to disomy by employing counter-selection markers. Upon construction of cells carrying markers targeted in one of the trisomic chromosome 2s, cells that have lost markers integrated in chromosome 2 were subsequently selected. The loss of one of the chromosome 2s had little impacts on the proliferative capacity, indicating unsubstantial role of the additional chromosome 2 in DT40 cells. We next tested large-scale truncations of chromosome 2 to make a mini-chromosome for the assessment of chromosome stability by introducing telomere repeat sequences to delete most of p-arm or q-arm of chromosome 2. The obtained cell lines had 0.7 Mb mini-chromosome, and approximately 0.2% of mini-chromosome was lost per cell division in wild-type background while the rate of chromosome loss was significantly increased by the depletion of DDX11, a cohesin regulatory protein. Collectively, our findings propose that trisomic chromosomes are good targets to make unique artificial chromosomes. Nature Publishing Group UK 2021-09-10 /pmc/articles/PMC8433146/ /pubmed/34508128 http://dx.doi.org/10.1038/s41598-021-97580-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Abe, Takuya Suzuki, Yuya Ikeya, Teppei Hirota, Kouji Targeting chromosome trisomy for chromosome editing |
title | Targeting chromosome trisomy for chromosome editing |
title_full | Targeting chromosome trisomy for chromosome editing |
title_fullStr | Targeting chromosome trisomy for chromosome editing |
title_full_unstemmed | Targeting chromosome trisomy for chromosome editing |
title_short | Targeting chromosome trisomy for chromosome editing |
title_sort | targeting chromosome trisomy for chromosome editing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433146/ https://www.ncbi.nlm.nih.gov/pubmed/34508128 http://dx.doi.org/10.1038/s41598-021-97580-1 |
work_keys_str_mv | AT abetakuya targetingchromosometrisomyforchromosomeediting AT suzukiyuya targetingchromosometrisomyforchromosomeediting AT ikeyateppei targetingchromosometrisomyforchromosomeediting AT hirotakouji targetingchromosometrisomyforchromosomeediting |